世界の遺伝子組換え型ヒトトロンボポエチン（rhTPO）市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Recombinant Human Thrombopoietin (rhTPO) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-105X14218 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、遺伝子組換え型ヒトトロンボポエチン（rhTPO）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子組換え型ヒトトロンボポエチン（rhTPO）の種類別市場規模（rhTPO、融合タンパク質）、用途別市場規模（医薬品、科学研究）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・遺伝子組換え型ヒトトロンボポエチン（rhTPO）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Qilu Pharmaceutical、R&D Systems、Merck、Shionogi、MedChemExpress、PeproTech、Kelun ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：rhTPO、融合タンパク質 ・用途別分析2016年-2026年：医薬品、科学研究 ・遺伝子組換え型ヒトトロンボポエチン（rhTPO）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・遺伝子組換え型ヒトトロンボポエチン（rhTPO）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・遺伝子組換え型ヒトトロンボポエチン（rhTPO）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・遺伝子組換え型ヒトトロンボポエチン（rhTPO）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・遺伝子組換え型ヒトトロンボポエチン（rhTPO）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Recombinant Human Thrombopoietin (rhTPO) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Recombinant Human Thrombopoietin (rhTPO) size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Recombinant Human Thrombopoietin (rhTPO) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Recombinant Human Thrombopoietin (rhTPO) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
rhTPO
Fusion Protein

Market segment by Application can be divided into
Medication
Scientific Research

The key market players for global Recombinant Human Thrombopoietin (rhTPO) market are listed below:
Qilu Pharmaceutical
R&D Systems
Merck
Shionogi
MedChemExpress
PeproTech
Kelun

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Recombinant Human Thrombopoietin (rhTPO) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Human Thrombopoietin (rhTPO) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 rhTPO
1.2.3 Fusion Protein
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Human Thrombopoietin (rhTPO) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Medication
1.3.3 Scientific Research
1.4 Global Recombinant Human Thrombopoietin (rhTPO) Market Size & Forecast
1.4.1 Global Recombinant Human Thrombopoietin (rhTPO) Sales in Value (2016-2026))
1.4.2 Global Recombinant Human Thrombopoietin (rhTPO) Sales in Volume (2016-2026)
1.4.3 Global Recombinant Human Thrombopoietin (rhTPO) Price by Type (2016-2026) & (USD/g)
1.5 Global Recombinant Human Thrombopoietin (rhTPO) Production Capacity Analysis
1.5.1 Global Recombinant Human Thrombopoietin (rhTPO) Total Production Capacity (2016-2026)
1.5.2 Global Recombinant Human Thrombopoietin (rhTPO) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Human Thrombopoietin (rhTPO) Market Drivers
1.6.2 Recombinant Human Thrombopoietin (rhTPO) Market Restraints
1.6.3 Recombinant Human Thrombopoietin (rhTPO) Trends Analysis
2 Manufacturers Profiles
2.1 Qilu Pharmaceutical
2.1.1 Qilu Pharmaceutical Details
2.1.2 Qilu Pharmaceutical Major Business
2.1.3 Qilu Pharmaceutical Recombinant Human Thrombopoietin (rhTPO) Product and Services
2.1.4 Qilu Pharmaceutical Recombinant Human Thrombopoietin (rhTPO) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 R&D Systems
2.2.1 R&D Systems Details
2.2.2 R&D Systems Major Business
2.2.3 R&D Systems Recombinant Human Thrombopoietin (rhTPO) Product and Services
2.2.4 R&D Systems Recombinant Human Thrombopoietin (rhTPO) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Recombinant Human Thrombopoietin (rhTPO) Product and Services
2.3.4 Merck Recombinant Human Thrombopoietin (rhTPO) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Shionogi
2.4.1 Shionogi Details
2.4.2 Shionogi Major Business
2.4.3 Shionogi Recombinant Human Thrombopoietin (rhTPO) Product and Services
2.4.4 Shionogi Recombinant Human Thrombopoietin (rhTPO) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 MedChemExpress
2.5.1 MedChemExpress Details
2.5.2 MedChemExpress Major Business
2.5.3 MedChemExpress Recombinant Human Thrombopoietin (rhTPO) Product and Services
2.5.4 MedChemExpress Recombinant Human Thrombopoietin (rhTPO) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 PeproTech
2.6.1 PeproTech Details
2.6.2 PeproTech Major Business
2.6.3 PeproTech Recombinant Human Thrombopoietin (rhTPO) Product and Services
2.6.4 PeproTech Recombinant Human Thrombopoietin (rhTPO) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Kelun
2.7.1 Kelun Details
2.7.2 Kelun Major Business
2.7.3 Kelun Recombinant Human Thrombopoietin (rhTPO) Product and Services
2.7.4 Kelun Recombinant Human Thrombopoietin (rhTPO) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Recombinant Human Thrombopoietin (rhTPO) Sales by Manufacturer
3.1 Global Recombinant Human Thrombopoietin (rhTPO) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Recombinant Human Thrombopoietin (rhTPO) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Recombinant Human Thrombopoietin (rhTPO)
3.4 Market Concentration Rate
3.4.1 Top 3 Recombinant Human Thrombopoietin (rhTPO) Manufacturer Market Share
3.4.2 Top 6 Recombinant Human Thrombopoietin (rhTPO) Manufacturer Market Share
3.5 Global Recombinant Human Thrombopoietin (rhTPO) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Recombinant Human Thrombopoietin (rhTPO) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Recombinant Human Thrombopoietin (rhTPO) Market Size by Region
4.1.1 Global Recombinant Human Thrombopoietin (rhTPO) Sales in Volume by Region (2016-2026)
4.1.2 Global Recombinant Human Thrombopoietin (rhTPO) Revenue by Region (2016-2026)
4.2 North America Recombinant Human Thrombopoietin (rhTPO) Revenue (2016-2026)
4.3 Europe Recombinant Human Thrombopoietin (rhTPO) Revenue (2016-2026)
4.4 Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Revenue (2016-2026)
4.5 South America Recombinant Human Thrombopoietin (rhTPO) Revenue (2016-2026)
4.6 Middle East and Africa Recombinant Human Thrombopoietin (rhTPO) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Recombinant Human Thrombopoietin (rhTPO) Sales in Volume by Type (2016-2026)
5.2 Global Recombinant Human Thrombopoietin (rhTPO) Revenue by Type (2016-2026)
5.3 Global Recombinant Human Thrombopoietin (rhTPO) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Recombinant Human Thrombopoietin (rhTPO) Sales in Volume by Application (2016-2026)
6.2 Global Recombinant Human Thrombopoietin (rhTPO) Revenue by Application (2016-2026)
6.3 Global Recombinant Human Thrombopoietin (rhTPO) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2016-2026)
7.2 North America Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2016-2026)
7.3 North America Recombinant Human Thrombopoietin (rhTPO) Market Size by Country
7.3.1 North America Recombinant Human Thrombopoietin (rhTPO) Sales in Volume by Country (2016-2026)
7.3.2 North America Recombinant Human Thrombopoietin (rhTPO) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2016-2026)
8.2 Europe Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2016-2026)
8.3 Europe Recombinant Human Thrombopoietin (rhTPO) Market Size by Country
8.3.1 Europe Recombinant Human Thrombopoietin (rhTPO) Sales in Volume by Country (2016-2026)
8.3.2 Europe Recombinant Human Thrombopoietin (rhTPO) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2016-2026)
9.2 Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2016-2026)
9.3 Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Market Size by Region
9.3.1 Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2016-2026)
10.2 South America Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2016-2026)
10.3 South America Recombinant Human Thrombopoietin (rhTPO) Market Size by Country
10.3.1 South America Recombinant Human Thrombopoietin (rhTPO) Sales in Volume by Country (2016-2026)
10.3.2 South America Recombinant Human Thrombopoietin (rhTPO) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2016-2026)
11.2 Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2016-2026)
11.3 Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Market Size by Country
11.3.1 Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Recombinant Human Thrombopoietin (rhTPO) Typical Distributors
12.3 Recombinant Human Thrombopoietin (rhTPO) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Recombinant Human Thrombopoietin (rhTPO) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Recombinant Human Thrombopoietin (rhTPO) Revenue by Application, (USD Million), 2021-2026
Table 3. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Qilu Pharmaceutical Major Business
Table 5. Qilu Pharmaceutical Recombinant Human Thrombopoietin (rhTPO) Product and Services
Table 6. Qilu Pharmaceutical Recombinant Human Thrombopoietin (rhTPO) Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. R&D Systems Basic Information, Manufacturing Base and Competitors
Table 8. R&D Systems Major Business
Table 9. R&D Systems Recombinant Human Thrombopoietin (rhTPO) Product and Services
Table 10. R&D Systems Recombinant Human Thrombopoietin (rhTPO) Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Recombinant Human Thrombopoietin (rhTPO) Product and Services
Table 14. Merck Recombinant Human Thrombopoietin (rhTPO) Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Shionogi Basic Information, Manufacturing Base and Competitors
Table 16. Shionogi Major Business
Table 17. Shionogi Recombinant Human Thrombopoietin (rhTPO) Product and Services
Table 18. Shionogi Recombinant Human Thrombopoietin (rhTPO) Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. MedChemExpress Basic Information, Manufacturing Base and Competitors
Table 20. MedChemExpress Major Business
Table 21. MedChemExpress Recombinant Human Thrombopoietin (rhTPO) Product and Services
Table 22. MedChemExpress Recombinant Human Thrombopoietin (rhTPO) Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. PeproTech Basic Information, Manufacturing Base and Competitors
Table 24. PeproTech Major Business
Table 25. PeproTech Recombinant Human Thrombopoietin (rhTPO) Product and Services
Table 26. PeproTech Recombinant Human Thrombopoietin (rhTPO) Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Kelun Basic Information, Manufacturing Base and Competitors
Table 28. Kelun Major Business
Table 29. Kelun Recombinant Human Thrombopoietin (rhTPO) Product and Services
Table 30. Kelun Recombinant Human Thrombopoietin (rhTPO) Sales (KG), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Recombinant Human Thrombopoietin (rhTPO) Sales by Manufacturer (2019-2021e) & (KG)
Table 32. Global Recombinant Human Thrombopoietin (rhTPO) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Recombinant Human Thrombopoietin (rhTPO), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Recombinant Human Thrombopoietin (rhTPO) Production Capacity by Company, (KG): 2020 VS 2021
Table 35. Head Office and Recombinant Human Thrombopoietin (rhTPO) Production Site of Key Manufacturer
Table 36. Global Recombinant Human Thrombopoietin (rhTPO) Sales by Region (2016-2021e) & (KG)
Table 37. Global Recombinant Human Thrombopoietin (rhTPO) Sales by Region (2021-2026) & (KG)
Table 38. Global Recombinant Human Thrombopoietin (rhTPO) Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Recombinant Human Thrombopoietin (rhTPO) Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2016-2021e) & (KG)
Table 41. Global Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2021-2026) & (KG)
Table 42. Global Recombinant Human Thrombopoietin (rhTPO) Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Recombinant Human Thrombopoietin (rhTPO) Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Recombinant Human Thrombopoietin (rhTPO) Price by Type (2016-2021e) & (USD/g)
Table 45. Global Recombinant Human Thrombopoietin (rhTPO) Price by Type (2021-2026) & (USD/g)
Table 46. Global Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2016-2021e) & (KG)
Table 47. Global Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2021-2026) & (KG)
Table 48. Global Recombinant Human Thrombopoietin (rhTPO) Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Recombinant Human Thrombopoietin (rhTPO) Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Recombinant Human Thrombopoietin (rhTPO) Price by Application (2016-2021e) & (USD/g)
Table 51. Global Recombinant Human Thrombopoietin (rhTPO) Price by Application (2021-2026) & (USD/g)
Table 52. North America Recombinant Human Thrombopoietin (rhTPO) Sales by Country (2016-2021e) & (KG)
Table 53. North America Recombinant Human Thrombopoietin (rhTPO) Sales by Country (2021-2026) & (KG)
Table 54. North America Recombinant Human Thrombopoietin (rhTPO) Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Recombinant Human Thrombopoietin (rhTPO) Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2016-2021e) & (KG)
Table 57. North America Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2021-2026) & (KG)
Table 58. North America Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2016-2021e) & (KG)
Table 59. North America Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2021-2026) & (KG)
Table 60. Europe Recombinant Human Thrombopoietin (rhTPO) Sales by Country (2016-2021e) & (KG)
Table 61. Europe Recombinant Human Thrombopoietin (rhTPO) Sales by Country (2021-2026) & (KG)
Table 62. Europe Recombinant Human Thrombopoietin (rhTPO) Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Recombinant Human Thrombopoietin (rhTPO) Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2016-2021e) & (KG)
Table 65. Europe Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2021-2026) & (KG)
Table 66. Europe Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2016-2021e) & (KG)
Table 67. Europe Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2021-2026) & (KG)
Table 68. Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Sales by Region (2016-2021e) & (KG)
Table 69. Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Sales by Region (2021-2026) & (KG)
Table 70. Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2016-2021e) & (KG)
Table 73. Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2021-2026) & (KG)
Table 74. Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2016-2021e) & (KG)
Table 75. Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2021-2026) & (KG)
Table 76. South America Recombinant Human Thrombopoietin (rhTPO) Sales by Country (2016-2021e) & (KG)
Table 77. South America Recombinant Human Thrombopoietin (rhTPO) Sales by Country (2021-2026) & (KG)
Table 78. South America Recombinant Human Thrombopoietin (rhTPO) Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Recombinant Human Thrombopoietin (rhTPO) Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2016-2021e) & (KG)
Table 81. South America Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2021-2026) & (KG)
Table 82. South America Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2016-2021e) & (KG)
Table 83. South America Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2021-2026) & (KG)
Table 84. Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Sales by Country (2016-2021e) & (KG)
Table 85. Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Sales by Country (2021-2026) & (KG)
Table 86. Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2016-2021e) & (KG)
Table 89. Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Sales by Type (2021-2026) & (KG)
Table 90. Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2016-2021e) & (KG)
Table 91. Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Sales by Application (2021-2026) & (KG)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Recombinant Human Thrombopoietin (rhTPO) Typical Distributors
Table 95. Recombinant Human Thrombopoietin (rhTPO) Typical Customers
List of Figures
Figure 1. Recombinant Human Thrombopoietin (rhTPO) Picture
Figure 2. Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Type in 2020
Figure 3. rhTPO
Figure 4. Fusion Protein
Figure 5. Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Application in 2020
Figure 6. Medication
Figure 7. Scientific Research
Figure 8. Global Recombinant Human Thrombopoietin (rhTPO) Market Size, (USD Million) & (KG): 2020 VS 2021 VS 2026
Figure 9. Global Recombinant Human Thrombopoietin (rhTPO) Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Recombinant Human Thrombopoietin (rhTPO) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Recombinant Human Thrombopoietin (rhTPO) Sales (2016-2026) & (KG)
Figure 30. Global Recombinant Human Thrombopoietin (rhTPO) Production Capacity (2016-2026) & (KG)
Figure 31. Global Recombinant Human Thrombopoietin (rhTPO) Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Recombinant Human Thrombopoietin (rhTPO) Market Drivers
Figure 33. Recombinant Human Thrombopoietin (rhTPO) Market Restraints
Figure 34. Recombinant Human Thrombopoietin (rhTPO) Market Trends
Figure 35. Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Manufacturer in 2020
Figure 36. Global Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Manufacturer in 2020
Figure 37. Recombinant Human Thrombopoietin (rhTPO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Recombinant Human Thrombopoietin (rhTPO) Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Recombinant Human Thrombopoietin (rhTPO) Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Region (2016-2026)
Figure 41. Global Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Region (2016-2026)
Figure 42. North America Recombinant Human Thrombopoietin (rhTPO) Revenue (2016-2026) & (USD Million)
Figure 43. Europe Recombinant Human Thrombopoietin (rhTPO) Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Revenue (2016-2026) & (USD Million)
Figure 45. South America Recombinant Human Thrombopoietin (rhTPO) Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Revenue (2016-2026) & (USD Million)
Figure 47. Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Type (2016-2026)
Figure 48. Global Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Type (2016-2026)
Figure 49. Global Recombinant Human Thrombopoietin (rhTPO) Price by Type (2016-2026) & (USD/g)
Figure 50. Global Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Application (2016-2026)
Figure 51. Global Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Application (2016-2026)
Figure 52. Global Recombinant Human Thrombopoietin (rhTPO) Price by Application (2016-2026) & (USD/g)
Figure 53. North America Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Country (2016-2026)
Figure 54. North America Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Country (2016-2026)
Figure 55. North America Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Type (2016-2026)
Figure 56. North America Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Application (2016-2026)
Figure 57. Europe Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Country (2016-2026)
Figure 58. Europe Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Country (2016-2026)
Figure 59. Europe Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Type (2016-2026)
Figure 60. Europe Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Application (2016-2026)
Figure 65. South America Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Country (2016-2026)
Figure 66. South America Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Country (2016-2026)
Figure 67. South America Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Type (2016-2026)
Figure 68. South America Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Recombinant Human Thrombopoietin (rhTPO) Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source

---